These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34075468)

  • 21. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-Lymphocyte Ratio (NLR) for Preoperative Differentiation between Uterine Leiomyosarcoma (LMS) and Uterine Leiomyoma: A Case-Controlled Study.
    Srisutha P; Santibenchakul S; Ariyasriwatana C; Oranratanaphan S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):701-707. PubMed ID: 36853322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
    Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas.
    Kubik-Huch RA; Weston M; Nougaret S; Leonhardt H; Thomassin-Naggara I; Horta M; Cunha TM; Maciel C; Rockall A; Forstner R
    Eur Radiol; 2018 Aug; 28(8):3125-3137. PubMed ID: 29492599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.
    Ho KC; Dean Fang YH; Lin G; Ueng SH; Wu TI; Lai CH; Chueh HY; Chao A; Chang TC; Yen TC
    Contrast Media Mol Imaging; 2018; 2018():7890241. PubMed ID: 30018513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
    Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
    J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of atypical fibroids.
    Bolan C; Caserta MP
    Abdom Radiol (NY); 2016 Dec; 41(12):2332-2349. PubMed ID: 27826698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
    Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
    Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
    Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography and magnetic resonance imaging findings in dogs with vaginal leiomyoma and leiomyosarcoma.
    Tanaka T; Noguchi S; Wada Y; Yamazaki H; Nishida H; Akiyoshi H
    Vet Med Sci; 2022 Nov; 8(6):2337-2344. PubMed ID: 36063539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
    Ludwin A; Gawron I; Pityński K
    Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-Weighted Imaging for Differentiating Uterine Leiomyosarcoma From Degenerated Leiomyoma.
    Li HM; Liu J; Qiang JW; Zhang H; Zhang GF; Ma F
    J Comput Assist Tomogr; 2017; 41(4):599-606. PubMed ID: 27997438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
    Garcia N; Ulin M; Yang Q; Ali M; Bosland MC; Zeng W; Chen L; Al-Hendy A
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A scoring system for histopathologic and immunohistochemical evaluations of uterine leiomyosarcomas.
    Yoshida C; Ichimura T; Kawamura N; Nakano A; Kasai M; Sumi T; Ishiko O
    Oncol Rep; 2009 Oct; 22(4):725-31. PubMed ID: 19724849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
    Yamane T; Takaoka A; Kita M; Imai Y; Senda M
    Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.